Arvinas, Inc. (ARVN) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Arvinas, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.180 Good day and thank you for standing by. Welcome to the ARENA's first quarter 2026 earnings 00:00:05.180 -- 00:00:09.447 call. At this time, all participants are in listen-only mode. 00:00:09.447 -- 00:00:13.034 After the speaker's presentation, there will be a question and answer session. 00:00:13.034 -- 00:00:17.662 To ask a question during the session, you will need to press star 11 on your telephone. 00:00:17.662 -- 00:00:20.927 You will then hear an automated message advising your hand is raised. 00:00:20.927 -- 00:00:24.145 To withdraw your question, please press star 11 again. 00:00:24.145 -- 00:00:26.828 Please provide that today's conference has been recorded. 00:00:26.828 -- 00:00:29.551 I would like to hand the conference over to your first speaker today, Jeff Boyle, head 00:00:29.551 -- 00:00:32.833 of investment relations. Please go ahead. 00:00:34.437 -- 00:00:36.900 Good morning, everyone. Thank you for joining us. 00:00:36.900 -- 00:00:41.205 Earlier today, we issued a press release with our first quarter of 2026 financial results, 00:00:41.205 -- 00:00:46.030 which is available in the investor and media section of our website at arvenis.com. 00:00:46.030 -- 00:00:50.716 Joining us on the call today, we have Randy Keel, our president and CEO, Noah Berkowitz, 00:00:50.716 -- 00:00:55.840 our chief medical officer, Angelica Casey, our Chief Scientific Officer, and Andrew Sayek, 00:00:55.840 -- 00:01:00.786 our Chief Financial Officer. Before we begin, I'll remind you that today's discussion 00:01:00.786 -- 00:01:05.032 contains forward-looking statements that involve risks, uncertainties, and assumptions. 00:01:05.032 -- 00:01:08.737 These risks and uncertainties are outlined in today's press release and in the company...